Ellagic Acid Bioavailability and Metabolism after Single Dose Consumption of Pure Ellagic Acid Versus Pomegranate Juice (P06-031-19).

Jianfeng Long,Jieping Yang,Yuanqian Guo,Susanne Henning,Rupo Lee,Anna Rasmusen,Lijun Zhang,Qinyi Lu,David Heber,Zhaoping Li

DOI: https://doi.org/10.1093/cdn/nzz031.p06-031-19

2019-01-01

Current Developments in Nutrition

Abstract:Center for Human Nutrition, David Geffen School of Medicine at UCLA, Los Angeles.

What problem does this paper attempt to address?

Bioavailability and Bioactivity of Free Ellagic Acid Compared to Pomegranate Juice.

Jianfeng Long,Yuanqiang Guo,Jieping Yang,Susanne M. Henning,Ru-Po Lee,Anna Rasmussen,Lijun Zhang,Qing-Yi Lu,David Heber,Zhaoping Li

DOI: https://doi.org/10.1039/c9fo01683j

IF: 6.3173

2019-01-01

Food & Function

Abstract:Pomegranates are an excellent source of ellagic acid (EA), ellagitannins (ETs), anthocyanins and other phytochemicals. The health benefits of pomegranate (Pom) have been mainly related to its EA and ET content. The objective of the present study was to determine EA bioavailability and bioactivity from different sources such as pure/free or natural form (PomJ). This was a cross-over study with healthy volunteers consuming one dose of EA dietary supplement (500 mg free EA) vs. one serving of PomJ (237 mL, ∼120 mg of EA) in a random order. Our data showed that there was no difference in plasma EA concentration between PomJ and EA intake; however, urinary dimethylellagic acid glucuronide (DMEAG), normalized to creatinine, was significantly higher after the consumption of PomJ compared to EA. Plasma insulin at 1 h increased after PomJ consumption compared to the baseline while decreased after EA consumption compared to the baseline. Plasma glucose decreased below the baseline 2 h after the consumption of PomJ but not EA. Plasma leptin was significantly decreased at 1 and 2 h after PomJ and EA consumption. Plasma MCP1 decreased only after PomJ but not after pure EA consumption. To conclude, one serving of PomJ provided the same level of EA in blood, while the increase in phase II metabolism of EA and an acute suppression of plasma MCP1 were only observed after PomJ consumption, suggesting that other constituents present in PomJ, in addition to EA, are bioactive and likely play a role in regulating EA phase II metabolism.
Pomegranate Juice and Extracts Provide Similar Levels of Plasma and Urinary Ellagitannin Metabolites in Human Subjects

Navindra P. Seeram,Yanjun Zhang,Rodney McKeever,Susanne M. Henning,Ru-po Lee,Marc A. Suchard,Zhaoping Li,Steve Chen,Gail Thames,Alona Zerlin,Martha Nguyen,David Wang,Mark Dreher,David Heber

DOI: https://doi.org/10.1089/jmf.2007.650

2008-01-01

Journal of Medicinal Food

Abstract:Pomegranate juice ( PJ), a rich source of polyphenols including ellagitannins, has attracted much attention due to its reported health benefits. This has resulted in the consumption of liquid and powder pomegranate extracts as alternatives to PJ. Therefore establishing the bioavailability of polyphenols from these extract preparations is necessary. Sixteen healthy volunteers sequentially consumed, with a 1- week washout period between treatments, PJ ( 8 ounces, Wonderful fruit variety), a pomegranate polyphenol liquid extract ( POMxl, 8 ounces), and a pomegranate polyphenol powder extract ( POMxp, 1,000 mg). The three interventions provided 857, 776, and 755 mg of polyphenols as gallic acid equivalents, respectively. Plasma bioavailability, judged based on ellagic acid levels over a 6- hour period, did not show statistical differences in area under the curve for the three interventions: 0.14 +/- 0.05, 0.11 +/- 0.03, and 0.11 +/- 0.04 mu mol . hour/L for PJ, POMxl, and POMxp, respectively. The time of maximum concentration was delayed for POMxp ( 2.58 +/- 0.42 hours) compared to PJ ( 0.65 +/- 0.23 hours) and POMxl ( 0.94 +/- 0.06 hours). Urolithin-A glucuronide, a urinary metabolite of ellagic acid, was not significantly different with the three interventions, reaching levels of approximately 1,000 ng/mL. This study demonstrates that ellagitannin metabolites, delivered from pomegranate fruits, as PJ, POMxl, and POMxp, reach equivalent levels with a delay in time of maximum concentration of POMxp compared to PJ and POMxl.
Effect of Pomegranate Juice Consumption on Plasma Indole Propionic Acid, a Bacterial-Derived Tryptophan Metabolite (P20-003-19)

Susanne Henning,Jieping Yang,Rupo Lee,Jianjun Huang,Gary Small,Yuanqian Guo,David Heber,Zhaoping Li

DOI: https://doi.org/10.1093/cdn/nzz040.p20-003-19

2019-01-01

Current Developments in Nutrition

Abstract:Supported by Center for Human Nutrition, UCLA.
Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract

Fan Lei,Dong-Ming Xing,Lan Xiang,Yu-Nan Zhao,Wei Wang,Lu-Jun Zhang,Li-Jun Du

DOI: https://doi.org/10.1016/S1570-0232(03)00610-X

IF: 3.318

2005-01-01

Journal of Chromatography B

Abstract:Quantification of ellagic acid, the principal bioactive component of pomegranate leaf extract, in rats plasma following oral administration of pomegranate leaf extract was achieved by using a high-performance liquid chromatographic method. The calibration curve for ellagic acid was linear (r2=0.9998) ver the concentration range 0.026–1.3μg/ml. The intra- and inter-day assays of ellagic acid from rat plasma were less than 6.52% at concentration range from 26 to 1300ng/ml and good overall recoveries (94.5–102.4%) were found on same concentrations. The concentration–time profile was fitted with an open two-compartment system with lag time and its max concentration of ellagic acid in plasma was 213ng/ml only 0.55h after oral administration extract 0.8g/kg. The pharmacokinetic profile indicates that ellagic acid has poor absorption and rapid elimination after oral administration pomegranate leaf extract, and part of it was absorbed from stomach.
Pharmacokinetics and Ex‐vivo Bioactivties of Pomegranate Polyphenols in Humans

NP Seeram,S Henning,RP Lee,YT Niu,YJ Zhang,M Suchard,HS Scheuller,ZP Li,G Thames,D Heber

DOI: https://doi.org/10.1096/fasebj.20.5.a1019

2006-01-01

The FASEB Journal

Abstract:Pomegranate juice (PJ) contains abundant polyphenols including punicalagin, an ellagitannin (ET) that is largely responsible for its in vitro bioactivities. The pharmacokinetics (PK) of PJ polyphenols in human subjects remains uninvestigated. We evaluated PK parameters of PJ polyphenols in humans (n=19) after ingestion of PJ (180 mL containing 318 mg punicalagin). Blood was collected before and at 0.5, 1, 2, 3, 4, and 6h post administration. Urine (24 h) was collected on the day prior to ingestion, on the intervention day, and on the day after ingestion. Liquid chromatography mass spectroscopy (LC-MS) plasma analyses revealed ellagic acid (EA), a hydrolysis product of ETs, at Cmax = 18.64 ± 1.69 ng/mL, AUC = 50.07 ± 5.80 ng/h/mL, Tmax = 0.98 ± 0.059 h and T1/2E = 0.75 ± 0.078 h. LC-MS analyses of urine and plasma showed intact EA and EA-derivatives on the intervention day while further ET-breakdown products were detected on the post-ingestion day. Considerable inter-individual variability in metabolites was observed. Evaluation of biomarkers of oxidative stress by ex vivo plasma antioxidant status and lymphocyte 8-hydroxydeoxyguanosine to deoxyguanosine (8-OHdg/106dG) ratios (damage to lymphocyte DNA), did not show any significant differences after consumption of PJ. Our results provide useful data required for designing doses and dose frequencies in intervention studies with PJ polyphenols for purposes of evaluating their potential health benefits in humans. Supported by the Stewart and Lynda Resnick Revocable Trust.
Development of a liquid chromatography-tandem mass spectrometry (LC–MS/MS) method for characterizing pomegranate extract pharmacokinetics in humans

Yan-Hong Wang,Goutam Mondal,Washim Khan,Bill J. Gurley,Charles R. Yates

DOI: https://doi.org/10.1016/j.jpba.2023.115477

IF: 3.571

2023-05-24

Journal of Pharmaceutical and Biomedical Analysis

Abstract:Pomegranate extracts standardized to punicalagins are a rich source of ellagitannins including ellagic acid (EA). Recent evidence suggests that gut microbiota-derived urolithin (Uro) metabolites of ellagitannins are pharmacologically active. Studies have evaluated the pharmacokinetics of EA, however, little is known about the disposition of urolithin metabolites (urolithin A (UA) and B (UB)). To address this gap, we developed and applied a novel ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) assay for the characterization of EA and Uro oral pharmacokinetics in humans. Subjects (10/cohort) received a single oral dose (250 or 1000 mg) of pomegranate extract (Pomella® extract) standardized to contain not less than 30% punicalagins, <5% EA, and not less than 50% polyphenols. Plasma samples, collected over 48 h, were treated with β-glucuronidase and sulfatase to permit comparison between unconjugated and conjugated forms of EA, UA and UB. EA and urolithins were separated by gradient elution (acetonitrile/water, 0.1% formic acid) using a C 18 column connected to a triple quadrupole mass spectrometer operating in the negative mode. Conjugated EA exposure was ~5-8-fold higher than unconjugated EA for both dose groups. Conjugated UA was readily detectable beginning ~8 h post-dosing, however, unconjugated UA was detectable in only a few subjects. Neither form of UB was detected. Together these data indicate EA is rapidly absorbed and conjugated following oral administration of Pomella® extract. Moreover, UA's delayed appearance in the blood, primarily in the conjugated form, is consistent with gut microbiota-mediated metabolism of EA to UA, which is then rapidly converted to its conjugated form.

pharmacology & pharmacy,chemistry, analytical
Ellagic Acid and Its Microbial Metabolite Urolithin a Alleviate Diet-induced Insulin Resistance in Mice (OR24-03-19)

Jieping Yang,Yuanqian Guo,Susanne Henning,Brenda Chan,Jianfeng Long,Jin Zhong,Rebeca Acin-Perez,Anton Petcherski,Orian Shirihai,David Heber,Zhaoping Li

DOI: https://doi.org/10.1093/cdn/nzz031.or24-03-19

2019-01-01

Current Developments in Nutrition

Abstract:Center for Human Nutrition, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles.
Transport Behavior of Ellagic Acid of Pomegranate Leaf Tannins and Its Correlation with Total Cholesterol Alteration in HepG2 Cells.

Jiaqi Lan,Fan Lei,Lei Hua,Yugang Wang,Dongming Xing,Lijun Du

DOI: https://doi.org/10.1002/bmc.1150

2008-01-01

Biomedical Chromatography

Abstract:The aim of this study was to investigate whether ellagic acid in pomegranate leaf tannins could be transported into HepG2 cells and its transport behavior. High-performance liquid chromatography coupled-with a 996 photodiode array detector at 254 nm was applied. The mobile phase was an acetonitrile-water solution (containing 0.1% triethylamine, pH 3.0; 16:64, v/v, for determining ellagic acid in cells). The flow rate was 0.8 mL/min. Cells were incubated with pomegranate leaf tannins with 100 and 50 mu g/mL (containing 1.71 and 0.85 mu g/mL of ellagic acid, respectively) for a specific time, then lysed and sonicated in methanol to extract intracellular ellagic acid. A 10 mu L aliquot of sample was injected into the HPLC system to determine ellagic acid concentration. The results showed that ellagic acid in pomegranate leaf tannins could be transported into the cells, which was in correlation with total cholesterol alteration in the cells. This is the first time that the transport behavior of ellagic acid through HepG2 cells in vitro has been comprehensively demonstrated. Copyright (C) 2008 John Wiley & Sons, Ltd.
Prospective Randomized, Double-Blind, Placebo-Controlled Study of a Standardized Oral Pomegranate Extract on the Gut Microbiome and Short-Chain Fatty Acids

Raja K Sivamani,Mincy Chakkalakal,Adrianne Pan,Dawnica Nadora,Mildred Min,Ashley Dumont,Waqas A Burney,Cindy J Chambers

DOI: https://doi.org/10.3390/foods13010015

IF: 5.2

2023-12-19

Foods

Abstract:Punica granatum L., commonly known as the pomegranate, is an abundant source of polyphenols, including hydrolyzable ellagitannins, ellagic acid, anthocyanins, and other bioactive phytochemicals shown to be effective in defending against oxidative stress, and has immunomodulatory activities. Ellagitannins, and their hydrolyzed product ellagic acid, interact with the gut microbiota to yield secondary metabolites known as urolithins that may have health benefits. The objective of this study was to determine the effects of supplementation with a standardized punicalagin-enriched pomegranate extract, Pomella® (250 mg), on the gut microbiome, circulating short-chain fatty acids, and gut microbial-derived ellagitannin metabolite urolithins. A randomized, double-blind, placebo-controlled study was conducted over 4 weeks on healthy volunteers aged 25-55 years. Subjects were randomly assigned to receive either an oral supplement containing 75 mg of punicalagin or an oral placebo. Stool sample collection and venipuncture were performed to analyze the gut microbiome, SCFAs, and urolithin. There was no significant change in the gut microbial diversity in both cohorts after 4 weeks of intervention, but there was a significantly increased relative abundance of Coprococcus eutectus, Roseburia faecis, Roseburia inullnivorans, Ruminococcus bicirculans, Ruminococcus calidus, and Faecalibacterium prausnitzii. Pomegranate extract (PE) supplementation led to the augmentation of circulating propionate levels (p = 0.02) and an increasing trend for acetate levels (p = 0.12). The pomegranate extract (PE) supplementation group had an increased level of circulating urolithins compared to the placebo group (6.6% vs. 1.1%, p = 0.13). PE supplementation correlated with shifts in the gut microbiome and with higher circulating levels of propionate and acetate. Further studies should explore the implications in larger cohorts and over a longer duration.
Effects of Season, Variety, and Processing Method on Ellagic Acid Content in Pomegranate Leaves

Lan Xiang,Dongming Xing,Fan Lei,Wei Wang,Lizhen Xu,Lei Nie,Lijun Du

DOI: https://doi.org/10.1016/s1007-0214(08)70074-9

2008-01-01

Tsinghua Science & Technology

Abstract:Ellagic acid (EA) has aroused great interest worldwide owing to its antioxidant, anti-inflammatory, and anticarcinogenetic properties. The EA content in pomegranate leaf was measured in this study using high performance liquid chromatography to investigate the effects of season, variety, and processing method on the EA level. The results show that the EA content in 11 varieties of pomegranate from the Zaozhuang region in China range from 1.30 mg · g−1 to 6.46 mg · g−1 of dry weight in five consecutive seasons from June to October. An analysis of variance (ANOVA) shows that the EA content is significantly dependent on the season (p<0.05). The EA content increases significantly during the growing season to the highest level in September and October. The effect of the leaf variety on the EA content is less significant than the season. The processing methods have different effects on the EA content. Soaking for 24 hours slightly increases the EA content (p<0.05). Heating at 80°C or 100°C for 1 h after soaking has little influence on the EA content, while slow-fired cooking at high temperature significantly elevates the EA content (p<0.05). To improve quality and stability, several parameters such as leaf collection time, slow-fired cooking, and cooking time should be strictly controlled during the processing of pomegranate leaf tea and its extract.
A comprehensive study of pomegranate flowers polyphenols and metabolites in rat biological samples by high-performance liquid chromatography quadrupole time-of-flight mass spectrometry

Zainaipuguli Yisimayili,Rahima Abdulla,Qiang Tian,Yangyang Wang,Mingcang Chen,Zhaolin Sun,Zhixiong Li,Fang Liu,Haji Akber Aisa,Chenggang Huang

DOI: https://doi.org/10.1016/j.chroma.2019.460472

2019-10-25

Abstract:Pomegranate flowers is an ancient medicine that has commonly been used to treat various diseases such as diabetes. However, no reports are available on the metabolic profile of pomegranate flowers in vivo. In the present study, with the aid of HPLC-Q-TOF-MS2, 67 compounds were identified in pomegranate flowers extract, including 18 ellagitannins, 14 gallic acid and galloyl derivatives, five anthocyanins and 18 flavonoids. Seven compounds were firstly identified. In vivo, 22 absorbed compounds and 35 metabolites were identified in rat biosamples (urine, feces, plasma and tissues) after orally administered with pomegranate flowers extract. This result showed that not all compounds abundant in pomegranate flowers extract could be absorbed well in plasma and tissues. This finding also suggested a potential correlation between study on metabolic profile of these compounds in vivo and study on strategy of screening bioactivity of the isolates with in vitro cell systems evaluation. Notably, mono-glucuronide conjugated metabolite of ellagitannin compound (corilagin) was firstly identified. In addition, this is first report to identify phase II conjugate metabolites of ellagitannins in vivo after oral administration of ellagitannins-rich extracts (or foods). Thus, characterizing its multiple constitution, absorption and metabolic fate of these compounds in vivo is helpful to better analyze the active components in pomegranate flowers.
Recovery of Ellagic Acid from Pomegranate Peels with the Aid of Ultrasound-Assisted Alkaline Hydrolysis

Anastasia Kyriakoudi,Evmorfia Kalfa,Eleni Zymvrakaki,Natasa Kalogiouri,Ioannis Mourtzinos

DOI: https://doi.org/10.3390/molecules29112424

IF: 4.6

2024-05-22

Molecules

Abstract:The pomegranate processing industry generates worldwide enormous amounts of by-products, such as pomegranate peels (PPs), which constitute a rich source of phenolic compounds. In this view, PPs could be exploited as a sustainable source of ellagic acid, which is a compound that possesses various biological actions. The present study aimed at the liberation of ellagic acid from its bound forms via ultrasound-assisted alkaline hydrolysis, which was optimized using response surface methodology. The effects of duration of sonication, solvent:solid ratio, and NaOH concentration on total phenol content (TPC), antioxidant activity, and punicalagin and ellagic acid content were investigated. Using the optimum hydrolysis conditions (i.e., 32 min, 1:48 v/w, 1.5 mol/L NaOH), the experimental responses were found to be TCP: 4230 ± 190 mg GAE/100 g dry PPs; AABTS: 32,398 ± 1817 μmol Trolox/100 g dry PPs; ACUPRAC: 29,816 ± 1955 μmol Trolox/100 g dry PPs; 59 ± 3 mg punicalagin/100 g dry PPs; and 1457 ± 71 mg ellagic acid/100 g dry PPs. LC-QTOF-MS and GC-MS analysis of the obtained PP extract revealed the presence of various phenolic compounds (e.g., ellagic acid), organic acids (e.g., citric acid), sugars (e.g., fructose) and amino acids (e.g., glycine). The proposed methodology could be of use for food, pharmaceutical, and cosmetics applications, thus reinforcing local economies.

chemistry, multidisciplinary,biochemistry & molecular biology
Effect of ultrasound on the extraction of ellagic acid and hydrolysis of ellagitannins from pomegranate husk

Diana B. Muñiz-Márquez,Jorge E. Wong-Paz,Pedro Aguilar-Zárate,Leonardo Sepúlveda,Juan Buenrostro-Figueroa,Juan A. Ascacio-Valdés,Cristóbal N. Aguilar

DOI: https://doi.org/10.1016/j.eti.2021.102063

2021-11-01

Abstract:In this study, an ultrasound-assisted extraction (UAE) of ellagic acid (EA) from pomegranate husk was studied according to a central composite design (CCD) matrix and analyzed under response surface methodology (RSM). Effect of several factors such as temperature (26–93 °C), sonication time (4–55 min), concentration of solvent (aqueous ethanol, 24%–75%), and solid–liquid ratio (3–16 g/mL) were evaluated. EA yield was determined by high performance liquid chromatography (HPLC) analysis and then CCD model was validated. The best extraction conditions were at 93.60 °C of extraction temperature for 55.23 min using 75.23 % of aqueous ethanol and liquid/solid ratio of 3.27 mL/g of vegetal material obtaining a recovery of EA of 19.47 mg/g. In addition, four experiments were conducted to evaluate the extent to which the individual impact of sonication and temperature on EA extraction from pomegranate husk. A positive effect combined both factors was observed. On the other hand, the results could suggest that UAE has no effect on purified ellagitannins hydrolysis under conditions used in this study, indicating that increase in the EA yield is attributed only to the cell rupture. The optimal conditions of EA extraction from pomegranate husk established in this research could be applicable in the food and pharmaceutical industry due to the UAE method presents many advantages in comparison with conventional technologies.

environmental sciences,engineering, environmental,biotechnology & applied microbiology
Ellagic Acid Recovery by Solid State Fermentation of Pomegranate Wastes by Aspergillus niger and Saccharomyces cerevisiae: A Comparison

Federica Moccia,Adriana C. Flores-Gallegos,Mónica L. Chávez-González,Leonardo Sepúlveda,Stefania Marzorati,Luisella Verotta,Lucia Panzella,Juan A. Ascacio-Valdes,Cristobal N. Aguilar,Alessandra Napolitano

DOI: https://doi.org/10.3390/molecules24203689

IF: 4.6

2019-10-14

Molecules

Abstract:Fermentation in solid state culture (SSC) has been the focus of increasing interest because of its potential for industrial applications. In previous studies SSC of pomegranate wastes by Aspergillus niger has been extensively developed and optimized for the recovery of ellagic acid (EA), a high value bioactive. In this study we comparatively investigated the SSC of powdered pomegranate husks by A. niger and Saccharomyces cerevisiae and evaluated the recovery yields of EA by an ultrasound and microwave-assisted 7:3 water/ethanol extraction. Surprisingly enough, the yields obtained by S. cerevisiae fermentation (4% w/w) were found 5-fold higher than those of the A. niger fermented material, with a 10-fold increase with respect to the unfermented material. The EA origin was traced by HPLC analysis that showed a significant decrease in the levels of punicalagin isomers and granatin B and formation of punicalin following fermentation. Other extraction conditions that could warrant a complete solubilization of EA were evaluated. Using a 1:100 solid to solvent ratio and DMSO as the solvent, EA was obtained in 4% yields from S. cerevisiae fermented husks at a high purity degree. Hydrolytic treatment of S. cerevisiae fermented pomegranate husks afforded a material freed of the polysaccharides components that gave recovery yields of EA up to 12% w/w.

chemistry, multidisciplinary,biochemistry & molecular biology
Absorption and Metabolism of Urolithin A and Ellagic Acid in Mice and Their Cytotoxicity in Human Colorectal Cancer Cells

I-Chen Lin,Jin-Yi Wu,Chuan-Yin Fang,Shou-Chie Wang,Yi-Wen Liu,Shang-Tse Ho

DOI: https://doi.org/10.1155/2023/8264716

2023-09-05

Abstract:Background: Ellagic acid is a natural polyphenol compound found in pomegranates, walnuts, and many berries. It is not easily absorbed, but it could be metabolized to urolithins by the gut microbiota. Urolithin A, one of the ellagic acid metabolites, has been proved to prolong the lifespan of C. elegans and increases muscle function of mice. The purpose of this current study was to analyze the absorption and metabolites of urolithin A and ellagic acid in mice and the anticancer effects of urolithin A, urolithin B, and ellagic acid in colorectal cancer cells. Methods: Urolithin A and urolithin B were synthesized and analyzed by HPLC and NMR. A pharmacokinetic study of urolithin A was performed in mice by analyzing urolithin A and its metabolites in urines. Absorption and biotransformation of ellagic acid were also studied in mice by analyzing the plasma, liver, and feces. The cytotoxicity of urolithin A, urolithin B, and ellagic acid was assayed in SW480, SW620, HCT 116, and HT-29 cells. Results: Urolithin A and urolithin B were synthesized and purified to reach 98.1% and 99% purity, respectively, and the structures were identified by NMR. In urolithin A intake analysis, urolithin A was only detectable at 3 h, not at 6-24 h; it suggested that urolithin A was rapidly metabolized to some unknown metabolites. Using UPLC-MS/MS analysis, the metabolites might be urolithin A 3-O-glucuronide, urolithin A 3-sulfate, and urolithin A-sulfate glucuronide. After feeding mice with ellagic acid for consecutive 14 days, ellagic acid contents could be detected in the fecal samples, but not in plasma and liver, and urolithin A was not detected in all samples. It suggests that ellagic acid is not easily absorbed and that the biotransformation of ellagic acid to urolithin A by intestinal flora might be very low. From the cytotoxicity assay, it was found that there was anticancer effect in urolithin A and urolithin B but not in ellagic acid. In contrast, ellagic acid promoted the proliferation of SW480 and SW620 cells.
Formulation Strategies to Improve Oral Bioavailability of Ellagic Acid

Guendalina Zuccari,Sara Baldassari,Giorgia Ailuno,Federica Turrini,Silvana Alfei,Gabriele Caviglioli

DOI: https://doi.org/10.20944/preprints202004.0100.v1

2020-04-07

Abstract:Ellagic acid, a polyphenolic compound present in fruits and berries, has recently been object of extensive research for its antioxidant activity, which might be useful for the prevention and treatment of cancer, cardiovascular pathologies, and neurodegenerative disorders. Its protective role justifies numerous attempts to include it in functional food preparations and in dietary supplements not only to limit the unpleasant collateral effects of chemotherapy. However, ellagic acid use as chemopreventive agent has been debated because of its poor bioavailability associated to low solubility, limited permeability, first pass effect, and interindividual variability in gut microbial transformations. To overcome these drawbacks, various strategies for oral administration including solid dispersions, micro-nanoparticles, inclusion complexes, self-emulsifying systems, polymorphs have been proposed. Here, we have listed an updated description of pursued micro/nanotechnological approaches focusing on the fabrication processes and the features of the obtained products, as well as on the positive results yielded by in vitro and in vivo studies in comparison to the raw material. The micro/nano-sized formulations here described might be exploited for pharmaceutical delivery of this active, as well as for the production of nutritional supplements or for the enrichment of novel foods.
Pomegranate Supplementation Alleviates Dyslipidemia and the Onset of Non-Alcoholic Fatty Liver Disease in Wistar Rats by Shifting Microbiota and Producing Urolithin-like Microbial Metabolites

Guadalupe Sánchez-Terrón,Remigio Martínez,David Morcuende,Victor Caballero,Mario Estevez

DOI: https://doi.org/10.1039/d4fo00688g

IF: 6.3173

2024-04-06

Food & Function

Abstract:Non-alcoholic fatty liver disease (NAFLD), obesity and related chronic diseases remain one of the major non-communicable diseases with high mortality rates worldwide. While dietary sugars are known to be responsible for insulin resistance and metabolic syndrome (MetS), the underlying pathophysiological effects of sustained fructose consumption requires further elucidation. We hypothesize that, certain bioactive compounds (i.e. punicalagin and ellagic acid) from dietary pomegranate could counteract the harmful effects of sustained fructose consumption in terms of obesity and liver damage. The present study aimed to elucidate both the molecular mechanisms involved in the pathophysiology associated with fructose intake and the effect of a punicalagin-rich commercial pomegranate dietary supplement (P) used as nutritional strategy to alleviate fructose-induced metabolic impairments. Thus, nineteen Wistar rats fed on a basal commercial feed were supplemented with either 30% (w/v) fructose in drinking water (F; n=7) or 30% (w/v) fructose solution plus 0.2% (w/v) P (F+P; n=6) for 10 weeks. Results were compared to a control group fed on the basal diet and provided with drinking water (C; n=6). Body weights and energy intake were weekly registered. P supplementation decreased fat depots counteracted the dyslipidemia caused by F and improved markers of liver injury including steatosis. The study of the microbiota by metagenomics and the urine by untargeted MS-based metabolomics, revealed microbial metabolites from P that may be responsible for these health benefits.

biochemistry & molecular biology,food science & technology
Pomegranate (Punica granatum L.) and Its Rich Ellagitannins as Potential Inhibitors in Ulcerative Colitis

Huimin Li,Jingya Ruan,Jiayan Huang,Dingshan Yang,Haiyang Yu,Yuzheng Wu,Yi Zhang,Tao Wang

DOI: https://doi.org/10.3390/ijms242417538

IF: 5.6

2023-12-16

International Journal of Molecular Sciences

Abstract:Ulcerative colitis, an immune-mediated inflammatory disease of the gastrointestinal tract, places a significant financial burden on patients and the healthcare system. Recently, reviews of the pomegranate and the abundant medicinal applications of its ellagitannins, as well as its pharmacological action, phytochemicals, metabolism, and pharmacokinetics, have been completed. However, summaries on their anti-ulcerative colitis effects are lacking. Numerous preclinical animal investigations and clinical human trial reports demonstrated the specific therapeutic effects of pomegranate and the effect of its ellagitannins against ulcerative colitis. According to the literature collected by Sci-finder and PubMed databases over the past 20 years, this is the first review that has compiled references regarding how the rich ellagitannins found in pomegranate have altered the ulcerative colitis. It was suggested that the various parts of pomegranates and their rich ellagitannins (especially their primary components, punicalagin, and ellagic acid) can inhibit oxidant and inflammatory processes, regulate the intestinal barrier and flora, and provide an anti-ulcerative colitis resource through dietary management.

biochemistry & molecular biology,chemistry, multidisciplinary
Simultaneous process optimization of ultrasound-assisted extraction of polyphenols and ellagic acid from pomegranate (Punica granatum L.) flowers and its biological activities

Wenxia Wu,Shan Jiang,Mengmeng Liu,Shuge Tian

DOI: https://doi.org/10.1016/j.ultsonch.2021.105833

Abstract:This study was designed to optimize the extraction rate of total polyphenols and ellagic acid from pomegranate flowers. Single factors were investigated for liquid-to-material ratio (5-25), ethanol concentration (20%-60%), sonication time (5-60 min), and sonication power (150-500 W). The level range of the Box-Bokhen design was determined with respect to the single-factor results. The components of each index were normalized using the entropy weighting method for obtaining the comprehensive evaluation value. Under the actual conditions, the final optimization results were 17 for liquid-to-material ratio, 43% for ethanol concentration, 10 min for ultrasonic time, and 300 W for ultrasonic power. The extracts obtained under optimal conditions were tested for the inhibition of Streptococcus mutans and its biofilm, and results showed that pomegranate flowers exerted some inhibitory effects on the bacterium. Phosphomolybdenum and FRAP assays were used, and DPPH, ABTS, and O2- radical scavenging tests were conducted, indicating that pomegranate flower extracts have good antioxidant capacity.
Effects of drying methods and solvent extraction on quantification of major bioactive compounds in pomegranate peel waste using HPLC

Nishant Kumar,Pratibha,Neeraj,Rokayya Sami,Ebtihal Khojah,Amani H. Aljahani,Amina A. M. Al-Mushhin

DOI: https://doi.org/10.1038/s41598-022-11881-7

IF: 4.6

2022-05-14

Scientific Reports

Abstract:Bioactive compound characterization is an essential step for utilizing pomegranate peel waste as food and nutraceuticals ingredients. In the present investigation, the effects of different drying methods (freeze, tray-oven, and sun) and extraction solvents such as methanol, ethanol, water, acetone, and hexane were investigated on the extraction and recovery of major bioactive compounds (ellagic acid, gallic acid, quercetin, and punicalagin) of pomegranate peel for two pomegranate varieties (i.e., Bhagwa and Ganesh) using high-performance liquid chromatography (HPLC). The results indicated that the freeze dried pomegranate peel powder of both pomegranate varities potential to extraction higher amount of bioactive compounds with methanol as extraction solvent as compared to other drying methods and solvents. Freeze-dried peel powder of Bhagwa pomegranate showed a higher amount of gallic acid (32.2 mg/g), ellagic acid (13.6 mg/g), punicalagin (15.2 mg/g), and quercetin (2.5 mg/g) with methanol solvent as compared to the other extract of Bhagwa and Ganesh varieties. The basis on the results of the current study, it can be concluded that the freeze-drying method of drying pomegranate peel powder and methanol as an extraction solvent are effective to recover higher amounts of bioactive compounds that can be utilized in food and pharmaceutical sectors at commercial scale.

multidisciplinary sciences

Ellagic Acid Bioavailability and Metabolism after Single Dose Consumption of Pure Ellagic Acid Versus Pomegranate Juice (P06-031-19).

Bioavailability and Bioactivity of Free Ellagic Acid Compared to Pomegranate Juice.

Pomegranate Juice and Extracts Provide Similar Levels of Plasma and Urinary Ellagitannin Metabolites in Human Subjects

Effect of Pomegranate Juice Consumption on Plasma Indole Propionic Acid, a Bacterial-Derived Tryptophan Metabolite (P20-003-19)

Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract

Pharmacokinetics and Ex‐vivo Bioactivties of Pomegranate Polyphenols in Humans

Development of a liquid chromatography-tandem mass spectrometry (LC–MS/MS) method for characterizing pomegranate extract pharmacokinetics in humans

Ellagic Acid and Its Microbial Metabolite Urolithin a Alleviate Diet-induced Insulin Resistance in Mice (OR24-03-19)

Transport Behavior of Ellagic Acid of Pomegranate Leaf Tannins and Its Correlation with Total Cholesterol Alteration in HepG2 Cells.

Prospective Randomized, Double-Blind, Placebo-Controlled Study of a Standardized Oral Pomegranate Extract on the Gut Microbiome and Short-Chain Fatty Acids

Effects of Season, Variety, and Processing Method on Ellagic Acid Content in Pomegranate Leaves

A comprehensive study of pomegranate flowers polyphenols and metabolites in rat biological samples by high-performance liquid chromatography quadrupole time-of-flight mass spectrometry

Recovery of Ellagic Acid from Pomegranate Peels with the Aid of Ultrasound-Assisted Alkaline Hydrolysis

Effect of ultrasound on the extraction of ellagic acid and hydrolysis of ellagitannins from pomegranate husk

Ellagic Acid Recovery by Solid State Fermentation of Pomegranate Wastes by Aspergillus niger and Saccharomyces cerevisiae: A Comparison

Absorption and Metabolism of Urolithin A and Ellagic Acid in Mice and Their Cytotoxicity in Human Colorectal Cancer Cells

Formulation Strategies to Improve Oral Bioavailability of Ellagic Acid

Pomegranate Supplementation Alleviates Dyslipidemia and the Onset of Non-Alcoholic Fatty Liver Disease in Wistar Rats by Shifting Microbiota and Producing Urolithin-like Microbial Metabolites

Pomegranate (Punica granatum L.) and Its Rich Ellagitannins as Potential Inhibitors in Ulcerative Colitis

Simultaneous process optimization of ultrasound-assisted extraction of polyphenols and ellagic acid from pomegranate (Punica granatum L.) flowers and its biological activities

Effects of drying methods and solvent extraction on quantification of major bioactive compounds in pomegranate peel waste using HPLC